First published 9/29/2026, 7:56:15 PM · Last updated 9/29/2026, 7:56:30 PM

Genome-sequencing-based benchmarking of antimicrobial resistance, treatment outcomes and healthcare transmission events for Clostridioides difficile infection in Australian hospitals

Journal article reporting genome-sequencing-based benchmarking of antimicrobial resistance, treatment outcomes, and healthcare transmission events for Clostridioides difficile in Australian hospitals, published 2026-10-01 by Elsevier BV. The excerpt provides no additional study details or results.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 6/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 4/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 4/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 6/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 2/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The study concerns antimicrobial resistance and healthcare transmission of C. difficile in Australian hospitals, topics relevant to clinical practice and infection control.

Location

Sources

Genome-sequencing-based benchmarking of antimicrobial resistance, treatment outcomes and healthcare transmission events for Clostridioides difficile infection in Australian hospitals

Report an issue